Ardena Gent
Ardena Gent is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Participants
Sponsor Merck Sharp & Dohme LLC
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available4 trial-level findings · Read insights
- Amendments added two panels to explore higher MK-3508 doses.
- Planned doses were revised downward based on emerging pharmacokinetic data.
- An amendment added inclusion-criteria requirements and an additional stopping criterion.
- An amendment clarified concomitant-medication restrictions and study procedures and added safety monitoring.
These findings describe the trial, not the service provider’s performance or responsibility.
Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS)
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial evaluating the efficacy and safety of 2 doses of buloxibutid over 52 weeks in people with idiopathic pulmonary fibrosis.
Sponsor Vicore Pharma AB
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Ardena Gent?
The 2026-10-09 snapshot links Ardena Gent to 3 distinct CTIS trials. Recorded services include Medicinal product management, IMP OSF preparation. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Ardena Gent?
The most frequently recorded therapeutic areas are Immunology, Infectious Disease, Neurology, Respiratory. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Ardena Gent conducted?
The linked trials record locations in 7 countries, including Belgium, Poland, Austria, Germany, Greece. These are trial locations, not confirmed office locations or countries where Ardena Gent delivered services.
What can this page tell me about Ardena Gent's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Ardena Gent. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Ardena Gent